CuraCell Holding AB
European biotech developing personalized T-cell therapies for solid cancer tumors.
Oversigt
- Ukendt
- Medarbejdere
- Ukendt
- Omsætning
- 2020
- Grundlagt
Nøglebeslutningstagere
Håkan Hallberg
CFO
Lucas Arruda
Chief Scientific Officer
Thomas Schlegel
General Counsel
Jonas Båtelson
CEO
+3 flere kontakter i Funnelfeedr
Beskrivelse
CuraCell is a European biotech company focused on developing innovative T-cell therapies for the treatment of solid cancer tumors. The company utilizes its proprietary platform, CytoPLY, designed to significantly expand and activate the patient's own tumor-reactive T-cells. Their primary therapeutic...